SM
WINT

Sabby Management’s Windtree Therapeutics Inc WINT Stock Holding History

Sabby Management’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-345,712
Closed -$112K – 247
2017
Q2 		$112K Buy
345,712
+58,190
+20% +$67.8K 0.01% 193
2017
Q1 		$328K Sell
287,522
-46,892
-14% -$60.9K 0.02% 199
2016
Q4 		$415K Buy
334,414
+24,414
+8% +$45.1K 0.02% 209
2016
Q3 		$797K Sell
310,000
-138,509
-31% -$301K 0.03% 200
2016
Q2 		$866K Sell
448,509
-117,843
-21% -$285K 0.05% 172
2016
Q1 		$934K Buy
566,352
+42,099
+8% +$90.4K 0.05% 161
2015
Q4 		$1.57M Buy
524,253
+188,285
+56% +$772K 0.09% 150
2015
Q3 		$1.41M Buy
+335,968
New +$2.22M 0.06% 201
2014
Q4 		– Sell
-4,643
Closed -$120 – 311
2014
Q3 		$120 Sell
4,643
-17,904
-79% -$432K ﹤0.01% 232
2014
Q2 		$562K Buy
22,547
+285
+1% +$7.29K 0.02% 183
2014
Q1 		$670K Sell
22,262
-20,595
-48% -$693K 0.04% 159
2013
Q4 		$1.35M Buy
+42,857
New +$1.34M 0.09% 101

Other funds holding WINT

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Sabby Management's WINT Position: Q3 2017 in Review

Sabby Management sold out of Windtree Therapeutics Inc (WINT) in Q3 2017, closing a stake of 345,712 shares — an estimated $112K sold.

Sabby Management first reported a position in WINT in Q4 2013 and held it in 12 quarters. The position peaked at $1.57M in Q4 2015. 3 funds tracked by Wall St. Rank hold WINT as of Q3 2017.

  • Sabby Management reported no remaining Windtree Therapeutics Inc position as of Q3 2017 after selling out during the quarter.
  • Sabby Management sold 345,712 Windtree Therapeutics Inc shares in Q3 2017, an estimated $112K.
  • Sabby Management first reported a position in Windtree Therapeutics Inc in Q4 2013 and held it in 12 quarters.
  • Sabby Management's Windtree Therapeutics Inc position peaked at $1.57M in Q4 2015.
  • 3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q3 2017.

Based on Sabby Management's 13F filing for Q3 2017, filed 14 Nov 2017.